Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trygg Pharma to Start Clinical Study - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Trygg Pharma to Start Clinical Study

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Trygg Pharma, Inc., a subsidiary of Aker BioMarine, Oslo, Norway, is currently enrolling patients in its clinical trial, a Phase III clinical study assessing the efficacy of AKR 963—an investigational candidate drug developed by the company—for treating patients with severe hypertriglyceridemia.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters